RecallRadar

FDA Device recall Z-1722-2023

ICD DDPA2D1G COBALT XT DR MRI DF1 GOLD, Model Number DDPA2D1G

On 2023-06-28 the FDA classified a Class I recall of ICD DDPA2D1G COBALT XT DR MRI DF1 GOLD, Model Number DDPA2D1G by Medtronic Cardiac Rhythm And Heart Failure Crhf, citing there is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynch….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1722-2023
ClassificationClass I
Statusongoing
Initiated2023-05-10
Published2023-06-28
Last updated2026-09-13 11:56 UTC
CompanyMedtronic Cardiac Rhythm And Heart Failure Crhf
DistributionUS

Product

ICD DDPA2D1G COBALT XT DR MRI DF1 GOLD, Model Number DDPA2D1G; Implantable Cardioverter Defibrillators

Reason

There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) manufactured with a specific (glassed) feedthrough, including currently available ICDs and CRT-Ds.

Identifiers

code_infoGTIN 00763000615611. Lot Serial Numbers: RSL602260S, RSL602263S, RSL602265S

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1722-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.